Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people lose between 1 and 3 kg in their first month on Wegovy. That figure is real, but it tells only part of the story: the first four weeks are a settling-in period as much as a results period, and what your body is doing behind the scenes matters more than the number on the scale. Wegovy (semaglutide) is a prescription-only medicine, and the dose you start on (0.25 mg) is a tolerability dose, not the therapeutic strength you'll eventually reach. A GPhC-registered prescriber assesses whether it's right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just done your first Wegovy injection. The needle's in the sharps bin, the pen is back in the fridge door, and you're probably wondering how soon you'll notice a difference. Here's the honest version: week one is usually quiet on the scales. The 0.25 mg dose is the gentlest rung on the titration ladder, calibrated to reduce the chance of nausea rather than to produce rapid weight change. Your appetite may dip slightly. Some people feel fuller faster at meals and eat a little less without thinking about it.
If you want a clearer sense of what Wegovy weight loss in the first month actually looks like, the two can be hard to separate on a home scale, which is one reason the first month can feel underwhelming compared to what you've read online. Stick with it. The meaningful results tend to build from month two onwards as the dose increases and appetite suppression deepens.
Nausea, loose stools, or a strange aversion to foods you normally enjoy are all common in these early weeks. They're the body adapting to the medicine's effect on gastric emptying. For most people, GI symptoms settle within two to three weeks of each dose change. Keeping meals smaller and avoiding very fatty foods can help.
The STEP 1 trial (the core evidence base behind Wegovy's licence) followed 1,961 adults over 68 weeks and recorded a 15% average body-weight reduction at the 2.4 mg maintenance dose. The trial didn't publish separate month-one figures, but the weight-loss curve is well understood: it's gradual in the first eight weeks, then steepens as the dose climbs through 0.5 mg and 1.0 mg, and steepens further once patients reach the 1.7 mg and 2.4 mg levels. By month one, most participants would have been on the starter dose for all four weeks. If you're wondering how quickly you see weight loss with Wegovy, real-world data reported by NHS England suggests the pace of weight loss typically accelerates after the three-month mark.
None of this makes the first month pointless. The body is adjusting hormone signalling, appetite cues, and how it processes energy. That groundwork matters. People who push through the early side effects and stay consistent with the titration schedule tend to see the strongest long-term results. If you want to see how the numbers look in more detail, our results page breaks down the evidence more granularly.
The NHS semaglutide medicines page gives a plain-language overview of how the medicine works and what to expect during treatment.
The most commonly reported effects in the first four weeks are gastrointestinal: nausea (often strongest in the day or two after an injection), loose stools, constipation, reflux, and burping. Headache and fatigue appear in some people. These are recognised effects of GLP-1 receptor agonists and are listed in the Patient Information Leaflet.
A few symptoms need prompt medical attention. Severe, persistent abdominal pain that radiates to your back (with or without vomiting) should prompt you to contact a doctor or call 111 without delay; this can be a sign of pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update for GLP-1 medicines. Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing) also need emergency care. If you're unsure whether a symptom is serious, contact your prescribing team. At nume, aftercare support is available seven days a week.
Patients and healthcare professionals can report suspected side effects directly to the MHRA at yellowcard.mhra.gov.uk.
The medicine does the heavy lifting, but what sits around it shapes how well month one goes. Protein is worth prioritising: when appetite falls, it's easy to eat less of everything and end up short on it. Hydration matters too, particularly if nausea or diarrhoea is affecting fluid intake. Smaller, more frequent meals can ease GI symptoms better than three large ones.
Alcohol is worth going carefully with. Wegovy slows gastric emptying, and alcohol's effects can feel more pronounced. There are no hard rules in the licence, but most prescribers advise cutting back, especially early on.
Exercise doesn't need to be intense. A daily walk supports the treatment's effects and, more practically, gives many people an early lift in energy and mood during a period when the physical adjustments can be tiring.
If you're weighing yourself daily, expect variation, day-to-day fluctuations of a kilo or more are normal and aren't meaningful. Weekly weigh-ins, at the same time of day, give a cleaner picture. Some of our patients say the most useful thing they can do in month one is pay attention to hunger cues rather than the scales: the medicine is working when you find yourself stopping mid-meal because you're full, or forgetting to eat lunch altogether.
Curious about how the cost of Wegovy compares across providers? Our cost page covers what a legitimate private prescription typically includes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.